During the past decade, Valley Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 35 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 19 clinical trials were completed. i.e. 172.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Research" #1 sponsor was "AstraZeneca" with 15 trials, followed by "Eli Lilly and Company" with 14 trials sponsored, "Pfizer" with 9 trials sponsored, "Mannkind Corporation" with 5 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 5 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Research" #1 collaborator was "Bristol-Myers Squibb" with 7 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Valley Research" are "Type 2 Diabetes" (11 trials), "Type 2 Diabetes Mellitus" (8 trials), "Diabetes" (6 trials), "Diabetes Mellitus, Type 2" (6 trials) and "Diabetes Mellitus, Type 1" (5 trials). Many other conditions were trialed in "Valley Research" in a lesser frequency.

Most popular intervention types in "Valley Research" are "Drug" (49 trials), "Biological" (10 trials), "Device" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Dapagliflozin" (7 trials), "Insulin Degludec" (5 trials), "AC2993" (4 trials) and "Metformin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Valley Research" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Valley Research". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Valley Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Valley Research, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".